Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements

Abstract Background Epigenetic alteration is an important indicator of crosstalk between cancer cells and surrounding microenvironment components including mesenchymal stem cells (MSC). Human menstrual blood-derived stem cells (MenSCs) are novel source of MSCs which exert suppressive effects on canc...

Full description

Bibliographic Details
Main Authors: Yichen Wu, Xin Chen, Yongjia Zhao, Yanling Wang, Yifei Li, Charlie Xiang
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-019-1243-8
_version_ 1818144046036549632
author Yichen Wu
Xin Chen
Yongjia Zhao
Yanling Wang
Yifei Li
Charlie Xiang
author_facet Yichen Wu
Xin Chen
Yongjia Zhao
Yanling Wang
Yifei Li
Charlie Xiang
author_sort Yichen Wu
collection DOAJ
description Abstract Background Epigenetic alteration is an important indicator of crosstalk between cancer cells and surrounding microenvironment components including mesenchymal stem cells (MSC). Human menstrual blood-derived stem cells (MenSCs) are novel source of MSCs which exert suppressive effects on cancers via multiple components of microenvironmental paracrine signaling. However, whether MenSCs play a crucial role in the epigenetic regulation of cancer cells remains unknown. Methods Epigenetic alterations of hepatocellular carcinoma (HCC) mediated by MenSCs were examined by immunofluorescence, ELISA, and RT-PCR assays. The suppressive impact of MenSCs on HCC was investigated in vitro using CCK8, apoptosis, wound healing, and invasion assays and in vivo using a xenograft mice model. MeDIP-seq, hMeDIP-seq, and RNA-seq were used to identify the genome-wide pattern of DNA methylation and hydroxymethylation in HCC cells after MenSC therapy. Results We show that HCC cells display distinct genome-wide alterations in DNA hydroxymethylation and methylation after MenSC therapy. MenSCs exert an inhibitory effect on HCC growth via regulating 5-hmC and 5-mC abundance in the regulatory regions of oncogenic pathways including PI3K/AKT and MAPK signaling, especially in enhancers and promoters. FOXO3 expression is rescued via reversal of 5-hmC and 5-mC levels in its enhancers and contributes to the activation of downstream apoptosis. Inactivation of the MAPK pathway further disrupts c-myc-mediated epithelial-mesenchymal transitions (EMT). Additionally, chemotherapy resistance-associated genes including ID4 and HMGA1 are suppressed via amending 5-hmC and 5-mC abundance at their regulatory regions. HMGA1 and BYSL might be potential targets for gene-modified MSC therapy. Conclusions Our results confirm that MSCs could regulate the epigenetic mechanism of HCC cells and provide a novel concept for a modified MSC strategy or combination therapy with chemotherapeutics based on epigenetics.
first_indexed 2024-12-11T11:41:20Z
format Article
id doaj.art-777fafe92c2e44b0b9e7900a02cd5028
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-11T11:41:20Z
publishDate 2019-05-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-777fafe92c2e44b0b9e7900a02cd50282022-12-22T01:08:36ZengBMCStem Cell Research & Therapy1757-65122019-05-0110111510.1186/s13287-019-1243-8Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elementsYichen Wu0Xin Chen1Yongjia Zhao2Yanling Wang3Yifei Li4Charlie Xiang5State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang UniversityAbstract Background Epigenetic alteration is an important indicator of crosstalk between cancer cells and surrounding microenvironment components including mesenchymal stem cells (MSC). Human menstrual blood-derived stem cells (MenSCs) are novel source of MSCs which exert suppressive effects on cancers via multiple components of microenvironmental paracrine signaling. However, whether MenSCs play a crucial role in the epigenetic regulation of cancer cells remains unknown. Methods Epigenetic alterations of hepatocellular carcinoma (HCC) mediated by MenSCs were examined by immunofluorescence, ELISA, and RT-PCR assays. The suppressive impact of MenSCs on HCC was investigated in vitro using CCK8, apoptosis, wound healing, and invasion assays and in vivo using a xenograft mice model. MeDIP-seq, hMeDIP-seq, and RNA-seq were used to identify the genome-wide pattern of DNA methylation and hydroxymethylation in HCC cells after MenSC therapy. Results We show that HCC cells display distinct genome-wide alterations in DNA hydroxymethylation and methylation after MenSC therapy. MenSCs exert an inhibitory effect on HCC growth via regulating 5-hmC and 5-mC abundance in the regulatory regions of oncogenic pathways including PI3K/AKT and MAPK signaling, especially in enhancers and promoters. FOXO3 expression is rescued via reversal of 5-hmC and 5-mC levels in its enhancers and contributes to the activation of downstream apoptosis. Inactivation of the MAPK pathway further disrupts c-myc-mediated epithelial-mesenchymal transitions (EMT). Additionally, chemotherapy resistance-associated genes including ID4 and HMGA1 are suppressed via amending 5-hmC and 5-mC abundance at their regulatory regions. HMGA1 and BYSL might be potential targets for gene-modified MSC therapy. Conclusions Our results confirm that MSCs could regulate the epigenetic mechanism of HCC cells and provide a novel concept for a modified MSC strategy or combination therapy with chemotherapeutics based on epigenetics.http://link.springer.com/article/10.1186/s13287-019-1243-8Mesenchymal stem cellHCCEpigenetics5-HydroxymethylcytosineEnhancer
spellingShingle Yichen Wu
Xin Chen
Yongjia Zhao
Yanling Wang
Yifei Li
Charlie Xiang
Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements
Stem Cell Research & Therapy
Mesenchymal stem cell
HCC
Epigenetics
5-Hydroxymethylcytosine
Enhancer
title Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements
title_full Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements
title_fullStr Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements
title_full_unstemmed Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements
title_short Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements
title_sort genome wide dna methylation and hydroxymethylation analysis reveal human menstrual blood derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5 hmc in enhancer elements
topic Mesenchymal stem cell
HCC
Epigenetics
5-Hydroxymethylcytosine
Enhancer
url http://link.springer.com/article/10.1186/s13287-019-1243-8
work_keys_str_mv AT yichenwu genomewidednamethylationandhydroxymethylationanalysisrevealhumanmenstrualbloodderivedstemcellsinhibithepatocellularcarcinomagrowththroughoncogenicpathwaysuppressionviaregulating5hmcinenhancerelements
AT xinchen genomewidednamethylationandhydroxymethylationanalysisrevealhumanmenstrualbloodderivedstemcellsinhibithepatocellularcarcinomagrowththroughoncogenicpathwaysuppressionviaregulating5hmcinenhancerelements
AT yongjiazhao genomewidednamethylationandhydroxymethylationanalysisrevealhumanmenstrualbloodderivedstemcellsinhibithepatocellularcarcinomagrowththroughoncogenicpathwaysuppressionviaregulating5hmcinenhancerelements
AT yanlingwang genomewidednamethylationandhydroxymethylationanalysisrevealhumanmenstrualbloodderivedstemcellsinhibithepatocellularcarcinomagrowththroughoncogenicpathwaysuppressionviaregulating5hmcinenhancerelements
AT yifeili genomewidednamethylationandhydroxymethylationanalysisrevealhumanmenstrualbloodderivedstemcellsinhibithepatocellularcarcinomagrowththroughoncogenicpathwaysuppressionviaregulating5hmcinenhancerelements
AT charliexiang genomewidednamethylationandhydroxymethylationanalysisrevealhumanmenstrualbloodderivedstemcellsinhibithepatocellularcarcinomagrowththroughoncogenicpathwaysuppressionviaregulating5hmcinenhancerelements